| Literature DB >> 7637023 |
T S McKenna1, J Lubroth, E Rieder, B Baxt, P W Mason.
Abstract
Binding of foot-and-mouth disease virus (FMDV) to cells requires an arginine-glycine-aspartic acid (RGD) sequence in the capsid protein VP1. We have genetically engineered an FMDV in which these three amino acids have been deleted, producing a virus particle which is unable to bind to cells. Cattle vaccinated with these receptor binding site-deleted virions were protected from disease when challenged with a virulent virus, demonstrating that these RGD-deleted viruses could serve as the basis for foot-and-mouth disease vaccines safer than those currently in use. This strategy may prove useful in the development of vaccines for other viral diseases.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7637023 PMCID: PMC189442
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103